Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Barlocco

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
Mini Reviews in Medicinal Chemistry|October 9, 2002
Non peptidic ligands at the opioid receptor like-1 (ORL-1)D Barlocco, L Toma, G Cignarella
Drug Discovery Today|July 27, 2001
Monitor: molecules and profilesD Barlocco, S Langston, D Tranter
Drug Discovery Today|May 23, 2001
Monitor: molecules and profilesS Langston, D Barlocco, D Tranter
Journal of Computer-Aided Molecular Design|October 1, 1993
Computer-aided structure-affinity relationships in a set of piperazine and 3,8-diazabicyclo[3.2.1]octane derivatives binding to the mu-opioid receptorD Barlocco, G Cignarella, G Greco, et al.
Farmaco (Societa Chimica Italiana : 1989)|January 2, 2001
Synthesis and aldose reductase inhibitory activity of a new series of benz[h]cinnolinone derivativesL Costantino, G Rastelli, G Cignarella, et al.
Farmaco (Societa Chimica Italiana : 1989)|February 1, 1995
Synthesis of 1,4-disubstituted-2-methylpiperazines and study of their analgesic propertiesD Barlocco, N Brunello, M Bernardi, et al.
Journal of Medicinal Chemistry|June 1, 1990
Conformationally constrained congeners of 6-aryl-5-methyl-4,5-dihydro-3(2H)-pyridazinones active on the cardiovascular system: conformational studies by molecular mechanics calculations and 1H NMR spectroscopyL Toma, G Cignarella, D Barlocco, et al.
Farmaco (Societa Chimica Italiana : 1989)|October 1, 1989
Synthesis and pharmacological study of 4,4a,5,6-tetrahydro-4a-substituted-benzo(h)cinnolin-3(2H)onesD Barlocco, G A Pinna, L Carboni, et al.
European Journal of Medicinal Chemistry|April 29, 2000
The opioid-receptor-like 1 (ORL-1) as a potential target for new analgesicsD Barlocco, G Cignarella, G A Giardina, et al.
Mini Reviews in Medicinal Chemistry|July 23, 2003
Selective ACAT inhibitors as promising antihyperlipidemic, antiathero-sclerotic and anti-Alzheimer drugsM P Giovannoni, V Dal Piaz, C Vergelli, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Mini Reviews in Medicinal Chemistry|October 9, 2002
Non peptidic ligands at the opioid receptor like-1 (ORL-1)D Barlocco, L Toma, G Cignarella
Drug Discovery Today|July 27, 2001
Monitor: molecules and profilesD Barlocco, S Langston, D Tranter
Drug Discovery Today|May 23, 2001
Monitor: molecules and profilesS Langston, D Barlocco, D Tranter
Journal of Computer-Aided Molecular Design|October 1, 1993
Computer-aided structure-affinity relationships in a set of piperazine and 3,8-diazabicyclo[3.2.1]octane derivatives binding to the mu-opioid receptorD Barlocco, G Cignarella, G Greco, et al.
Farmaco (Societa Chimica Italiana : 1989)|January 2, 2001
Synthesis and aldose reductase inhibitory activity of a new series of benz[h]cinnolinone derivativesL Costantino, G Rastelli, G Cignarella, et al.
Farmaco (Societa Chimica Italiana : 1989)|February 1, 1995
Synthesis of 1,4-disubstituted-2-methylpiperazines and study of their analgesic propertiesD Barlocco, N Brunello, M Bernardi, et al.
Journal of Medicinal Chemistry|June 1, 1990
Conformationally constrained congeners of 6-aryl-5-methyl-4,5-dihydro-3(2H)-pyridazinones active on the cardiovascular system: conformational studies by molecular mechanics calculations and 1H NMR spectroscopyL Toma, G Cignarella, D Barlocco, et al.
Farmaco (Societa Chimica Italiana : 1989)|October 1, 1989
Synthesis and pharmacological study of 4,4a,5,6-tetrahydro-4a-substituted-benzo(h)cinnolin-3(2H)onesD Barlocco, G A Pinna, L Carboni, et al.
European Journal of Medicinal Chemistry|April 29, 2000
The opioid-receptor-like 1 (ORL-1) as a potential target for new analgesicsD Barlocco, G Cignarella, G A Giardina, et al.
Mini Reviews in Medicinal Chemistry|July 23, 2003
Selective ACAT inhibitors as promising antihyperlipidemic, antiathero-sclerotic and anti-Alzheimer drugsM P Giovannoni, V Dal Piaz, C Vergelli, et al.
Pageof 7